Machine Learning and Mendelian Randomization Reveal a Tumor Immune Cell Profile for Predicting Bladder Cancer Risk and Immunotherapy Outcomes
Mendelian Randomization
Cancer Immunotherapy
DOI:
10.1016/j.ajpath.2025.01.016
Publication Date:
2025-03-22T06:21:55Z
AUTHORS (12)
ABSTRACT
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (22)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....